Which MS shot hurts less? new study compares kesimpta and ocrevus
NCT ID NCT06668324
First seen Nov 01, 2025 · Last updated May 23, 2026 · Updated 29 times
Summary
This study looked at how people with multiple sclerosis felt about their first injection of either Kesimpta or a new under-the-skin version of Ocrevus. 134 adults who were just starting one of these drugs answered questions about pain, redness, swelling, and itching at the injection site. The goal was to see which treatment caused fewer injection reactions and which one patients were more satisfied with.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE SCLEROSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Novartis Investigative site
East Hanover, New Jersey, 07936, United States
Conditions
Explore the condition pages connected to this study.